Abstract:BACKGROUND:Alzheimer's disease (AD) is the most common form of dementia, characterized by progressive cognitive impairment and neurodegeneration. However, despite extensive clinical and genomic studies, the molecular basis of AD development and progression remains elusive.METHODS:To elucidate molecular systems associated with AD, we developed a large scale gene expression dataset from 1053 postmortem brain samples across 19 cortical regions of 125 individuals with a severity spectrum of dementia and neuropathology of AD. We excluded brain specimens that evidenced neuropathology other than that characteristic of AD. For the first time, we performed a pan-cortical brain region genomic analysis, characterizing the gene expression changes associated with a measure of dementia severity and multiple measures of the severity of neuropathological lesions associated with AD (neuritic plaques and neurofibrillary tangles) and constructing region-specific co-expression networks. We rank-ordered 44,692 gene probesets, 1558 co-expressed gene modules and 19 brain regions based upon their association with the disease traits.RESULTS:The neurobiological pathways identified through these analyses included actin cytoskeleton, axon guidance, and nervous system development. Using public human brain single-cell RNA-sequencing data, we computed brain cell type-specific marker genes for human and determined that many of the abnormally expressed gene signatures and network modules were specific to oligodendrocytes, astrocytes, and neurons. Analysis based on disease severity suggested that: many of the gene expression changes, including those of oligodendrocytes, occurred early in the progression of disease, making them potential translational/treatment development targets and unlikely to be mere bystander result of degeneration; several modules were closely linked to cognitive compromise with lesser association with traditional measures of neuropathology. The brain regional analyses identified temporal lobe gyri as sites associated with the greatest and earliest gene expression abnormalities.CONCLUSIONS:This transcriptomic network analysis of 19 brain regions provides a comprehensive assessment of the critical molecular pathways associated with AD pathology and offers new insights into molecular mechanisms underlying selective regional vulnerability to AD at different stages of the progression of cognitive compromise and development of the canonical neuropathological lesions of AD.

Macroscale connectome topographical structure reveals the biomechanisms of brain dysfunction in Alzheimer's disease

Macroscale Gradient Dysfunction in Alzheimer's Disease: Patterns With Cognition Terms and Gene Expression Profiles

Gray matter structural covariance networks changes along the Alzheimer's disease continuum.

Mapping the Alzheimer's brain with connectomics.

Structural Insights into Aberrant Topological Patterns of Large-Scale Cortical Networks in Alzheimer'S Disease

Gray Matter Structural Covariance Networks Patterns Associated with Autopsy-Confirmed LATE-NC Compared to Alzheimer's Disease Pathology.

Diffusion tensor tractography reveals abnormal topological organization in structural cortical networks in Alzheimer's disease.

Altered Topological Properties of Functional Brain Network Associated with Alzheimer's Disease

Aberrant topological organization and age-related differences in the human connectome in subjective cognitive decline by using regional morphology from magnetic resonance imaging

Disrupted Structural and Functional Brain Connectomes in Mild Cognitive Impairment and Alzheimer's Disease.

Connectome-wide network analysis of white matter connectivity in Alzheimer's disease.

Convergent Neuroimaging and Molecular Signatures in Mild Cognitive Impairment and Alzheimer’s Disease: A Data-Driven Meta-Analysis with N = 3,118

Consistent genes associated with structural changes in clinical Alzheimer's disease spectrum

Topographic metabolism‐function relationships in Alzheimer's disease: A simultaneous PET/MRI study

Age-related differences in the topological efficiency of the brain structural connectome in amnestic mild cognitive impairment.

Functional connectome hierarchy dysfunction in Alzheimer's disease and its relationship with cognition and gene expression profiling

Age-Related Decline in the Topological Efficiency of the Brain Structural Connectome and Cognitive Aging.

Topologically convergent and divergent large scale complex networks among Alzheimer's disease spectrum patients: A systematic review

Integrative Network Analysis of Nineteen Brain Regions Identifies Molecular Signatures and Networks Underlying Selective Regional Vulnerability to Alzheimer’s Disease

Multiomics Reveals Biological Mechanisms Linking Macroscale Structural Covariance Network Dysfunction with Neuropsychiatric Symptoms Across the Alzheimer’s Disease Continuum

Convergent Neuroimaging and Molecular Signatures in Mild Cognitive Impairment and Alzheimer's Disease: A Data-Driven Meta-Analysis with N = 3,118